Detailed Information on Publication Record
2017
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry
GRAEFF, Luisa Durán, Danila SEIDEL, Maria J. G. T. VEHRESCHILD, Axel HAMPRECHT, Anupma KINDO et. al.Basic information
Original name
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry
Authors
GRAEFF, Luisa Durán (276 Germany), Danila SEIDEL (276 Germany), Maria J. G. T. VEHRESCHILD (276 Germany), Axel HAMPRECHT (276 Germany), Anupma KINDO (356 India), Zdeněk RÁČIL (203 Czech Republic, guarantor, belonging to the institution), Judit DEMETER (348 Hungary), Sybren De HOOG (528 Netherlands), Ute AURBACH (276 Germany), Maren ZIEGLER (276 Germany), Hilmar WISPLINGHOFF (276 Germany) and Oliver A. CORNELY (276 Germany)
Edition
Mycoses, Hoboken, Wiley-Blackwell, 2017, 0933-7407
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30216 Dermatology and venereal diseases
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.793
RIV identification code
RIV/00216224:14110/17:00096159
Organization unit
Faculty of Medicine
UT WoS
000395433700009
Keywords in English
Geotrichum; invasive fungal diseases; Saprochaete
Tags
Tags
International impact, Reviewed
Změněno: 15/3/2018 16:33, Soňa Böhmová
Abstract
V originále
Saprochaete and Geotrichum spp. are rare emerging fungi causing invasive fungal diseases in immunosuppressed patients and scarce evidence is available for treatment decisions. Among 505 cases of rare IFD from the FungiScope™ registry, we identified 23 cases of invasive infections caused by these fungi reported from 10 countries over a 12-year period. All cases were adults and previous chemotherapy with associated neutropenia was the most common co-morbidity. Fungaemia was confirmed in 14 (61%) cases and deep organ involvement included lungs, liver, spleen, central nervous system and kidneys. Fungi were S. capitata (n=14), S. clavata (n=5), G. candidum (n=2) and Geotrichum spp. (n=2). Susceptibility was tested in 16 (70%) isolates. All S. capitata and S. clavata isolates with the exception of one S. capitata (MIC 4 mg/L) isolate had MICs>32 mg/L for caspofungin. For micafungin and anidulafungin, MICs varied between 0.25 and >32 mg/L. One case was diagnosed postmortem, 22 patients received targeted treatment, with voriconazole as the most frequent first line drug. Overall mortality was 65% (n=15). Initial echinocandin treatment was associated with worse outcome at day 30 when compared to treatment with other antifungals (amphotericin B ± flucytosine, voriconazole, fluconazole and itraconazole) (P=.036). Echinocandins are not an option for these infections.